<DOC>
	<DOC>NCT00292734</DOC>
	<brief_summary>Primary objective: To show that the combination of Zolpidem + antidepressant therapy is more effective in the treatment of the secondary insomnia of depressive and dysthimic patients than antidepressant therapy alone in the acute phase of the disease.</brief_summary>
	<brief_title>STILDEP: Zolpidem in Depressive and Dysthimic Patients</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Depressive and dysthimic patients in acute phase of mild to moderate severity Depressive and dysthimic patients suffering from secondary insomnia (DSM IV) recent antidepressant therapy (less than 1 week) Regularly use of sleeping pills in the last 23 month Use of any sleeping pils in the last week Insufficient hepatic Myasthenia gravis Proven hypersensivity to Zolpidem Evidence of clinically relevant nervous system disorders (other neurologic/psychiatric diseases associated with depression) History of evidence of alcohol or drug abuse Evidence of clinically relevant cardiovascular, haematologic, hepatic, gastrointestinal, renal, pulmonary or endocrinologic diseases Abnormal snore Work an alternating shift Suffering from periodic leg movement disorder and sleep apnea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>